Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:00 PM
Ignite Modification Date:
2025-12-24 @ 11:00 PM
NCT ID:
NCT03319069
Eligibility Criteria:
Inclusion Criteria:
* Ipsilateral clinically diagnosed and histologically confirmed invasive breast cancer
* Undergone total mastectomy and axillary dissection T 3-4 and/or 4 or more positive axillary lymph nodes.
* Fit for chemotherapy ( if indicated) , endocrine therapy (if indicated), and postoperative irradiation.
* Written informed concent.
* C T3-4 , or C N2, or pathological positive axillary lymph nodes during mastectomy for patients who had received neoadjuvant chemotherapy or hormone therapy.
* No supraclavicular or internal mammary nodes metastases.
* No distant metastases .Enrollment date no more than 8 months after surgery or no more than 2 months after chemotherapy for patients who did't receive neoadjuvant therapy.
* Enrollment date no more than 2 months after surgery for patients who had received neoadjuvant systemic therapy and did't need adjuvant chemotherapy.
Exclusion Criteria:
* Patients who undergone previous irradiation to the ipsilateral chest wall and supraclavicular region
* Previous or concurrent malignant other than non melanomatous skin cancer
* Bilateral breast cancer.
* Immediate or delayed ipsilateral breast cancer reconstruction.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT03319069
Study Brief:
Protocol Section:
NCT03319069